Compare CVS Health Corp (CVS) vs Illinois Tool Works Inc. (ITW) Price & Performance

CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.

The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.

ITW trades at $261.15, down 2.24% on the day, with technical indicators showing bearish momentum as the stock tests support near $261. The company maintains strong fundamentals with a 19.39% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights ITW's dividend increase to $1.72 per share, reinforcing its status as a Dividend King with 59 years of consecutive increases.

The outlook remains mixed with solid profitability offset by bearish technicals. Upside potential exists toward the $276.86 analyst consensus target, but investors face headwinds from weak technical momentum and mixed analyst sentiment where only 21% recommend buying. Key risks include debt levels rising to 55.54% of assets and exposure to cyclical industrial demand.